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Abstract
Numerous creatine formulations have been developed primarily to maximize creatine absorption.
Creatine ethyl ester is alleged to increase creatine bio-availability. This study examined how a
seven-week supplementation regimen combined with resistance training affected body
composition, muscle mass, muscle strength and power, serum and muscle creatine levels, and
serum creatinine levels in 30 non-resistance-trained males. In a double-blind manner, participants
were randomly assigned to a maltodextrose placebo (PLA), creatine monohydrate (CRT), or
creatine ethyl ester (CEE) group. The supplements were orally ingested at a dose of 0.30 g/kg fat-
free body mass (approximately 20 g/day) for five days followed by ingestion at 0.075 g/kg fat free
mass (approximately 5 g/day) for 42 days. Results showed significantly higher serum creatine
concentrations in PLA (p = 0.007) and CRT (p = 0.005) compared to CEE. Serum creatinine was
greater in CEE compared to the PLA (p = 0.001) and CRT (p = 0.001) and increased at days 6, 27,
and 48. Total muscle creatine content was significantly higher in CRT (p = 0.026) and CEE (p =
0.041) compared to PLA, with no differences between CRT and CEE. Significant changes over time
were observed for body composition, body water, muscle strength and power variables, but no
significant differences were observed between groups. In conclusion, when compared to creatine
monohydrate, creatine ethyl ester was not as effective at increasing serum and muscle creatine
levels or in improving body composition, muscle mass, strength, and power. Therefore, the
improvements in these variables can most likely be attributed to the training protocol itself, rather
than the supplementation regimen.
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Introduction
Creatine is found in small quantities within the brain,
liver, kidneys, and testes, while approximately 95% of cre-
atine stores are found in skeletal muscle [1]. Creatine or
methyl guanidine acetic acid is supplied by exogenous
sources such as fish and red meat and is endogenously
synthesized from the amino acids arginine, glycine, and
methionine [2]. Energy is provided to the body from the
hydrolysis of ATP into adenosine diphosphate (ADP) and
inorganic phosphate (Pi). The phosphagen system pro-
vides a rapid resynthesis of ATP from ADP with the use of
phosphocreatine (PCr) through the reversible reaction of
creatine kinase [2-4]. Of the 95% of creatine stored within
skeletal muscle, approximately 40% is free creatine and
approximately 60% is PCr [3]. The average 70 kg person
has a total creatine pool of 120–140 g. Specifically, the
range of creatine in skeletal muscle is 110–160 mmol/kg
dry mass [2,1,5]. Creatine supplementation has the ability
to increase skeletal muscle stores of creatine and PCr,
which could therefore increase skeletal muscle's ability to
increase ATP resynthesis from ADP. A previous study [6]
employing 20 g of creatine for 6 days showed an increase
in PCr concentrations after a maximal isometric contrac-
tion during 16 and 32 seconds of recovery. Resistance
training along with creatine supplementation has typi-
cally been shown to be more beneficial at increasing body
mass, maximal strength, and weight lifting performance
compared to placebo, but responses are variable [7].
With the ergogenic benefits consistently being shown in
both research settings and among the general population,
creatine has become one of the most recognized ergogenic
aids to date. Intramuscular stores of creatine are consid-
ered to be saturated at 160 mmol/kg dry mass; however,
only 20% of users achieve this amount and another 20–
30% do not respond to creatine supplementation at all
[1]. Several hundred studies have examined creatine sup-
plementation's effectiveness in improving muscle per-
formance. Approximately 70% of these studies have
shown statistically significant performance improve-
ments, with the remaining studies generally producing
non-significant trends [8]. Aside from differences such as
experimental design, amount and duration of creatine
dosage, training status of participants, etc., the variance in
response to creatine supplementation may be due to reg-
ulatory mechanisms of a sodium-chloride dependent cre-
atine transporter. The creatine transporter is directly
involved in the extracellular uptake of creatine to increase
the pool of metabolically active creatine in muscle [9]. It
appears that intramuscular creatine uptake is dependent
on creatine transporter activity, which has resulted in
numerous creatine formulations having been developed
in an attempt to improve muscle creatine uptake and
potentially increasing the efficacy of creatine supplemen-
tation [10].
Due to variations in intramuscular creatine uptake in
response to creatine supplementation, it has been sug-
gested that creatine alone may have a limited ability to
maximally activate the creatine transporter. Numerous
creatine formulations have been developed recently
which combine creatine with carbohydrate, sodium, or
esterified alcohol with the primary intent of improving
cellular absorption and transport which may maximize
total intramuscular creatine concentration, thereby
improving muscular performance. These new products
may prove beneficial increasing creatine uptake by up-reg-
ulating or by-passing the creatine transporter. A compari-
son of creatine monohydrate, creatine with dextrose, and
effervescent creatine showed added benefit when dextrose
is combined with creatine, but no additional benefits of
effervescent creatine compared to creatine monohydrate
[11]. Another study combined creatine with magnesium
and showed no additional performance benefits com-
pared to creatine monohydrate [12]. Additionally, creat-
ine solubilized in liquid was ineffective at increasing
creatine retention compared to creatine monohydrate [8].
The molecular structure of creatine consists of a negatively
charged carboxyl group and a positively charged func-
tional group [13]. Creatine is a polar molecule and
hydrophilic due to this composition, which limits creat-
ine bioavailability. Esterification is a process widely used
by pharmaceutical companies to increase bioavailability
of certain prescription drugs with low bioavailability. In a
continued attempt to more effectively increase intramus-
cular creatine levels, one of the latest creatine variations is
creatine ethyl ester. Esterification of creatine decreases its
hydrophilicity, and is alleged by manufacturers of creatine
ethyl ester to by-pass the creatine transporter due to
enhanced sarcolemmal permeability toward creatine.
However, there are no published data to substantiate this
allegation. Furthermore, esterified creatine is unstable in
low pH conditions [14,15], and has been shown to be rap-
idly degraded to creatinine in stomach acid [16]. Even so,
manufacturers of creatine ethyl ester claim that it is supe-
rior to other forms of creatine, but there is also no pub-
lished scientific evidence substantiate these claims.
Therefore, the effectiveness of creatine ethyl ester has not
yet been adequately researched and currently no pub-
lished data exists to substantiate the alleged effectiveness
of this supplement.
The primary purpose of the study was to determine the
extent to which creatine ethyl ester affects muscle strength
and power, body composition, serum and muscle creatine
levels, and serum creatinine levels.Journal of the International Society of Sports Nutrition 2009, 6:6 http://www.jissn.com/content/6/1/6
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Methods
Participants
Thirty apparently healthy males with a mean age of 20.43
± 1.71 years, height of 176.67 ± 8.02 cm, and total body
mass of 80.35 ± 18.52 kg served as participants in the
study. The participants were not resistance-trained [not
following a consistent resistance training program (i.e.
thrice weekly) for at least one year prior to the study], but
were recreationally-active. All participants were cleared for
participation by passing a mandatory medical screening.
Participants with contraindications to exercise as outlined
by the American College of Sports Medicine and/or who
had consumed any nutritional supplements (excluding
multi-vitamins) such creatine monohydrate or various
androstenedione derivatives or pharmacologic agents
such as anabolic steroids three months prior to the study
were not allowed to participate. All eligible subjects
signed a university-approved informed consent docu-
ment. Additionally, all experimental procedures involved
in this study conformed to the ethical considerations of
the Helsinki Code.
Testing sessions
The study included baseline testing at day 0, followed by
testing sessions at days 6, 27, and 48 in which blood and
muscle samples were obtained and where body composi-
tion and muscle performance tests were performed.
Strength assessment
The leg press and bench press maximal strength tests
(Nebula, Versailles, OH) were performed by the partici-
pants to measure any changes in muscular strength during
the course of the study. Four one repetition maximum (1-
RM) strength tests were performed during the study at
days 0, 6, 27, and 48. Initially, an estimated 50% (1-RM)
measured from the previous testing 1-RM test, was uti-
lized to complete 5 to 10 repetitions. After a two minute
rest period, a load of 70% of estimated (1-RM) was uti-
lized to perform 3 to 5 repetitions. Weight was gradually
increased until a 1-RM was reached with each following
lift, with a two-minute rest period in between each suc-
cessful lift. Test-retest reliability of performing these
strength assessments on subjects within our laboratory
has demonstrated low mean coefficients of variation and
high reliability for the bench press (1.9%, intraclass r =
0.94) and leg press (0.7%, intraclass r = 0.91), respec-
tively.
Anaerobic power test
Anaerobic power was determined during each of the four
testing sessions at days 0, 6, 27, and 48, and expressed rel-
ative to body mass. The determinations were made by per-
forming a 30-second Wingate test on a computerized
Lode cycle ergometer (Groningen, Netherlands). A warm-
up of 30 rpm for 120 seconds was followed by maximal
sprint for 30 seconds against a workload of 0.075 kg/kg of
body weight. Correlation coefficients of test-retest reliabil-
ity of performing these assessments of absolute peak
power and mean power on participants within our labo-
ratory has been found to be r = 0.692 and r = 0.950,
respectively.
Body composition assessment
Total body mass (kg) was determined on a standard dual
beam balance scale (Detecto Bridgeview, IL). Percent
body fat, fat mass, and fat-free mass were determined
using DEXA (Hologic Discovery Series W, Waltham, MA).
Quality control calibration procedures were performed on
a spine phantom (Hologic X-CALIBER Model DPA/QDR-
1 anthropometric spine phantom) and a density step cal-
ibration phantom prior to each testing session. The DEXA
scans were segmented into regions (right & left arm, right
& left leg, and trunk). Each of these segments was ana-
lyzed for fat mass, lean mass, and bone mass. A sub-region
was utilized to determine right thigh mass. The isolated
region extended medially to the pubic symphysis down to
the head of the femur. Total body water and compart-
ment-specific fluid volumes were determined by bioelec-
tric impedance analysis (Xitron Technologies Inc., San
Diego, CA) using a low energy, high frequency current
(500 micro-amps at a frequency of 50 kHz). Based on pre-
vious studies in our laboratory, the accuracy of the DEXA
for body composition assessment is ± 2% as assessed by
direct comparison with hydrodensitometry and scale
weight.
Supplementation protocol
Participants were randomly assigned to one of three
groups in a double blind manner in which they orally
ingested capsules and powder which contained either dex-
trose placebo [PLC (AST Sport Science, Colorado Springs,
CO)], creatine monohydrate [CRT (Integrity Nutraceuti-
cals, Sarasota, FL)], or creatine ethyl ester [CEE (Labrada
Nutritionals, Houston, TX)]. For CRT, each capsule con-
tained 250 mg of creatine monohydrate; however, for CEE
each capsule contained 700 mg of creatine ethyl ester.
Quality control testing of the creatine ethyl ester supple-
ment using NMR from an independent laboratory from
the University of Nebraska determined the product to
contain 100% creatine ethyl ester HCL, with no detectable
creatine HCL or creatinine HCL. The creatine supplement
was shown to contain 99.8% creatine monohydrate and
0.2% creatinine.
After baseline testing procedures and fat-free mass deter-
mination by DEXA, supplements placebo were ingested
relative to fat-free mass based on previous guidelines [17]
for 48 days (loading from days 1–5 and maintenance
from days 6–48.). Specifically, supplements were ingested
at a relative daily dose of 0.30 g/kg fat-free body massJournal of the International Society of Sports Nutrition 2009, 6:6 http://www.jissn.com/content/6/1/6
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(approximately 20 g/day) during the loading phase, and
at a relative daily dose of 0.075 g/kg fat free mass (approx-
imately 5 g/day) during the maintenance phase. After the
initial baseline assessment of body composition at day 0,
supplement dosages were subsequently adjusted based on
body composition assessments performed at days 6 and
27.
In order to standardize supplement intake throughout the
study, participants were instructed to ingest the supple-
ments in two equal intervals, one in the morning and one
in the evening, throughout the day during the loading
phase [13], and at one constant interval, in the morning,
during the maintenance phase. Compliance to the supple-
mentation protocol was monitored by supplement logs
and verbal confirmation. After completing the compli-
ance procedures the subjects were given the required sup-
plement dosage for the following supplementation
period.
Resistance training protocol
Participants engaged in a 4-day per week resistance-train-
ing program split into two upper and two lower extremity
workouts per week for a total of seven weeks. The upper
body resistance-training program consisted of nine exer-
cises (bench press, lat pull, shoulder press, seated rows,
shoulder shrugs, chest flies, biceps curl, triceps press
down, and abdominal curls) twice per week and a seven
exercise lower extremity program (leg press or squat, back
extension, step ups, leg curls, leg extension, heel raises,
and abdominal crunches) performed twice per week. We
have previously shown this program to be effective at pro-
moting significant gains in muscle strength and mass [18].
Participants performed 3 sets of 8–10 repetitions with 70–
80% 1-RM. Rest periods between exercises lasted no
longer than three minutes and rest between sets lasted no
longer than two minutes. Training sessions were not
supervised, but were documented in training logs, and
signed off to verify compliance and to monitor progress.
Muscle biopsies and venous blood sampling
Based on our previously-established guidelines [18], at
each of the four testing sessions at days 0, 6, 27, and 48
percutaneous muscle biopsies (50–70 mg) were obtained
using a Bergstrom (5 mm) needle. Muscle samples were
obtained from the middle portion of the vastus lateralis
muscle of the dominant leg at the midpoint between the
patella and the greater trochanter of the femur, at a depth
between one and two cm. For the remaining three biop-
sies, attempts were made to extract tissue from approxi-
mately the same location as the initial biopsy by using the
pre-biopsy scar, depth markings on the needle, and a suc-
cessive incision that was made approximately 0.5 cm to
the former from medial to lateral. After removal, the mus-
cle specimens were immediately frozen in liquid nitrogen
and then stored at -80°C for later analysis.
At each of the four testing sessions, venous blood samples
were obtained from the antecubital vein using a standard
Vacutainer apparatus. Once collected, the samples were
centrifuged for 15 minutes. The serum was removed and
frozen at -80°C for later analysis. An 8-hour fast prior to
blood donation was required for the participants before
each of the four testing sessions.
Muscle and serum creatine analysis
Muscle tissue samples were analyzed spectrophotometri-
cally for total creatine by the diacetyl/α-napthtol reaction
[19]. Using similar methods, serum samples were meas-
ured in duplicate for creatine concentration. Serum sam-
ples were immediately ready for creatine analysis, whereas
muscle tissue had to first be prepared. For serum creatine
analysis, duplicates for all samples yielded a coefficient of
variation of 5.4%.
Approximately 10–15 mg of muscle tissue was cut and
placed in a microfuge tube, and then placed in a vacuum
centrifuge (Savant ISS110 SpeedVac™ Concentrator,
Thermo Scientific, Milford, MA) to be spun for 18–24
hours. After sufficient muscle drying, the samples were
then placed in an ultra-low freezer at -80°C. Dried muscle
was powdered by grinding on a porcelain plate with a pes-
tle. Connective tissue was removed and discarded,
whereas powdered muscle was placed into pre-weighed
microfuge tubes. Powdered muscle was extracted in a 0.5
M perchloric acid/1 mM EDTA solution on ice for 15-min-
utes, while periodically vortexing. Samples were then
spun at 15,000 rpm at 4°C for 5-minutes. The supernatant
was transferred into a microfuge tube and neutralized
with 2.1 M KHCO3/0.3 M MOPS solution and then cen-
trifuged again at 15,000 rpm for 5-minutes. In order to
determine muscle total creatine concentration, superna-
tant from the above reaction was combined with ddH2O
and 0.4 N HCl and heated at 65°C for 10-minutes to
hydrolyze phosphate groups. The solution was then neu-
tralized with of 2.0 N NaOH and the samples were
allowed to incubate at room temperature allowing for
color formation, which was detected by a spectrophotom-
eter at 520 nm. Then the samples were run in duplicate
against a standard curve of known creatine concentra-
tions. The mean correlation coefficient of variation
between duplicates was 1.53%. The standard curve corre-
lation coefficient between plates for total muscle creatine
was 0.998.
Dietary intake records and supplementation compliance
Throughout the course of the study, participants' dietary
intake was not supervised; however, it was required that
all participants keep detailed dietary records and notJournal of the International Society of Sports Nutrition 2009, 6:6 http://www.jissn.com/content/6/1/6
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change their routine dietary habits throughout the course
of the study. As such, participants were required to keep
weekly physical activity records and four-day dietary
records (three weekdays and one weekend) prior to each
of the four testing sessions. The four-day dietary recalls
were evaluated with the Food Processor dietary assess-
ment software program (ESHA Research, Salem, OR) to
determine the average daily macronutrient consumption
of fat, carbohydrate, and protein. The participants were
instructed to turn in their dietary records during each test-
ing session. Each participant returned all of their dietary
evaluations at the required time points for a 100% com-
pliance rate. In an effort to ensure compliance to the sup-
plementation protocol, participants were supplied with
the appropriate amount of supplement to be ingested dur-
ing the time between last three testing sessions. Upon
reporting to the lab for each testing session at days 6, 27,
and 48, participants returned the empty containers they
had acquired between testing sessions
Reported side effects from supplements
At the last three testing sessions, participants reported by
questionnaire whether they tolerated the supplement,
supplementation protocol, as well as report any medical
problems/symptoms they may have encountered
throughout the study.
Statistical analysis
Data were analyzed using separate 3 (group) × time [4]
univariate analysis of variance (ANOVA) with repeated
measures on the time factor with SPSS for Windows Ver-
sion 16.0 software (SPSS inc., Chicago, IL). Significant dif-
ferences among groups were identified by a Tukey HSD
post-hoc test. A probability level of ≤ 0.05 was adopted
throughout.
Results
Subject Demographics
Forty-two participants who were initially recruited for the
study completed consent forms and participated in an ini-
tial familiarization session. Of the 42 participants
recruited, 30 completed the 48-day research study. Five
participants dropped out due to illness unrelated to the
study, five due to apprehension about blood and muscle
sampling, and two did not provide specific reasons. How-
ever, none of the participants dropped out due to side
effects of the supplements or the resistance training proto-
col. Table 1 shows the sample size, along with the baseline
means (± SD) for height, weight, and age for each of the
three groups.
Dietary analysis, supplement compliance, and side effects
All participants appeared to have exhibited 100% compli-
ance with the supplement protocol, and were able to com-
plete the required dosing regimen and testing procedures
with no side effects reported from any of the supplements.
The diet logs were used to analyze the average caloric and
macronutrient consumption relative to total body mass.
No significant differences between groups were observed
for total kcal (p = 0.901), fat (p = 0.853), carbohydrates (p
= 0.871), and protein (p = 0.947). In addition, no signifi-
cant differences among the four testing sessions were
observed for total kcal (p = 0.947), fat (p = 0.956), carbo-
hydrates (p = 0.809), and protein (p = 0.948). This data
indicates that there were no significant differences
between groups over the course of the study for dietary
intake (Table 2).
Serum creatine
A significant difference among the three groups was
observed indicating significantly higher serum creatine
concentrations in the CRT group when compared to PLA
(p = 0.007) and CEE (p = 0.005) (Figure 1). Also, signifi-
cant differences for CRT occurred at days 6 (p = 0.028), 27
(p = 0.014), and 48 (p = 0.032). Muscle creatine
A significant difference among groups for total muscle cre-
atine indicated that total muscle creatine content was sig-
nificantly higher in the CRT (p = 0.026) and CEE (p =
0.041) groups when compared to the PLA group. Signifi-
cant differences over the course of the four testing sessions
were observed indicating that the CRT group underwent
increases in total muscle creatine at day 6 (p = 0.041) and
27 (p= 0.036), whereas CEE only increased at day 27 (p =
0.043) (Figure 2).
Serum creatinine
A significant difference over the course of the four testing
sessions (p = 0.001) and significant difference between
groups (p = 0.001) was observed for serum creatinine.
Serum creatinine was greater in the CEE group compared
to the PLA (p = 0.001) and CRT (p = 0.001) groups. Fur-
ther analysis revealed significant elevations in serum cre-
atinine with the CEE group that occurred days 6 (p =
0.007), 27 (p = 0.005), and 48 (p = 0.005) (Figure 3).
Body composition
There was no significant difference between groups for
total body mass (p = 0.173). However, a significant differ-
ence over the course of the four testing sessions was
Table 1: Baseline Participant Demographics
Group Group Size Height (cm) Bodyweight (kg) Age (yr)
PLA 10 175.39 (7.82) 77.91 (18.44) 20.16 (1.46)
CR 10 173.67 (9.14) 89.45 (22.14) 20.36 (1.53)
CEE 10 177.55 (6.79) 73.75 (14.98) 20.83 (2.21)Journal of the International Society of Sports Nutrition 2009, 6:6 http://www.jissn.com/content/6/1/6
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observed demonstrating that total body mass significantly
increased at days 6, 27, and 48 days 6 (p = 0.015), 27 (p =
0.006), and 48 (p = 0.027) (Table 3). A significant differ-
ence between groups (p = 0.043) was observed for fat
mass demonstrating that the CRT group had significantly
(p = 0.034) more fat mass than the CEE group. Addition-
ally, a significant difference over the course of the four
testing sessions was also observed indicating that signifi-
cant decreases in fat mass were observed at days 6 (p =
0.002), 27 (p = 0.001), and 48 (p = 0.003) (Table 3). For
fat-free mass, there was no significant difference between
groups (p = 0.137). However, a significant difference was
observed among the four testing sessions indicating that
fat-free mass significantly increased at days 6 (p = 0.001),
27 (p = 0.001), and 48 (p = 0.001). There was also a sig-
nificant increase at day 48 compared to days 6 (p = 0.012)
and 27 (p = 0.022) (Table 3). There was no significant dif-
ference between groups for thigh muscle mass (p =
0.236); however, a significant difference was observed
among the four testing sessions which revealed thigh
muscle mass to be significantly increased at days 27 (p =
0.017) and 48 (p = 0.016). Increases were also seen at day
27 (p = 0.012) and 48 (p = 0.041) compared to day 6
(Table 3).
Body water
There was no significant difference between groups for
total body water (p = 0.276). However, a significant differ-
ence existed among the four testing sessions indicating
that total body water was significantly increased at days 27
(p = 0.022) and 48 (p = 0.001). There was also a signifi-
cant increase at day 48 compared to day 6 (p = 0.002)
(Table 4). No significant difference between groups
existed for intracellular body water (p = 0.198). A signifi-
cant difference was observed among the four testing ses-
sions indicating there to be increases in intracellular body
water at days 27 (p = 0.023) and 48 (p = 0.001). There
were also significant increases at day 48 compared to days
6 (p = 0.001) and 27 (p = 0.002) (Table 4). For extracellu-
lar body water, there was no significant difference
Table 2: Dietary Caloric and Macronutrient Intake
Group/Time Calories (kcal/kg/day) Protein (g/kg/day) Carbohydrate (g/kg/day) Fat (g/kg/day)
PLA
Day 0 23.11 (9.29) 1.00 (0.57) 2.88 (1.06) 1.26 (0.485)
Day 6 25.93 (8.94) 1.11 (0.37) 3.29 (1.28) 1.30 (0.421)
Day 27 26.47 (7.14) 1.14 (0.34) 3.96 (1.09) 1.40 (0.501)
Day 48 26.32 (8.34) 1.19 (0.37) 3.24 (1.29) 1.34 (0.293)
CRT
Day 0 28.49 (9.79) 1.24 (0.50) 3.45 (1.35) 1.38 (0.405)
Day 6 29.67 (9.40) 1.31 (0.27) 3.18 (1.57) 1.43 (0.506)
Day 27 25.86 (8.36) 1.35 (0.38) 3.56 (1.19) 1.41 (0.445)
Day 48 28.43 (9.81) 1.31 (0.47) 3.20 (1.74) 1.51 (0.505)
CEE
Day 0 21.37 (9.79) 0.94 (0.31) 3.34 (0.82) 1.28 (0.475)
Day 6 19.66 (8.21) 0.97 (0.26) 3.19 (1.12) 1.39 (0.612)
Day 27 18.55 (6.62) 0.86 (0.28) 2.91 (0.95) 1.27 (0.366)
Day 48 17.18 (4.50) 0.79 (0.22) 2.82 (1.22) 1.29 (0.250)
Data are presented as mean (± SD) and expressed relative to total body mass. No significant differences existed between groups or testing sessions 
for total calories or calories from protein, carbohydrate, or fat (p > 0.05).Journal of the International Society of Sports Nutrition 2009, 6:6 http://www.jissn.com/content/6/1/6
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between groups (p = 0.478). A significant difference
among the four testing sessions was observed indicating
extracellular water to be significantly increased at day 27
(p = 0.042) (Table 4).
Muscle strength
For bench press strength, no significant difference was
observed between groups (p = 0.946); however, a signifi-
cant difference among the four testing sessions existed
indicating that bench press strength was significantly
increased at days 27 (p = 0.001) and 48 (p = 0.001). Bench
press strength was also significantly increased at day 27 (p
= 0.001) and 48 (p = 0.001) compared to day 6, and sig-
nificantly increased at day 48 compared to day 27 (p =
0.001) (Table 5). No significant difference between
groups was observed for leg press strength (p = 0.894).
However, a significant difference among the four testing
sessions was observed demonstrating that leg press
strength increased at days 6 (p = 0.021), 27 (p = 0.001),
and 48 (p = 0.001). Increases were also observed at day 27
(p = 0.001) compared to day 6 (Table 5).
Anaerobic Power
There were no significant differences between groups for
mean (p = 0.468) and peak (p = 0.705) power (Table 4).
However, significant differences among the four testing
sessions occurred for mean and peak power. Further anal-
ysis showed mean power to be increased at days 27 (p =
0.046) and 48 (p = 0.019), along with increases seen at
day 48 compared to day 6 (p = 0.029). Peak power was
increased at day 48 (p = 0.001). Additionally, peak power
was increased at day 48 compared to days 6 (p = 0.001)
and 27 (p = 0.029) (Table 6).
Discussion
The purpose of this study was to examine the effects of cre-
atine ethyl ester supplementation in combination with
heavy resistance training for 47 days compared to supple-
mentation with creatine monohydrate and a placebo. Fol-
Changes in serum creatine concentrations with data expressed as mean (± SD) Figure 1
Changes in serum creatine concentrations with data expressed as mean (± SD). † indicates significantly higher 
serum creatine concentrations in CRT when compared to PLA (p = 0.007) and CEE (p = 0.005). * indicates significant differ-
ences for CRT occurred at days 6 (p = 0.028), 27 (p = 0.014), and 48 (p = 0.032).Journal of the International Society of Sports Nutrition 2009, 6:6 http://www.jissn.com/content/6/1/6
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lowing a 5-day loading phase and a 42-day maintenance
phase, creatine ethyl ester was examined for changes in
muscle strength and mass, body composition changes,
serum creatine and creatinine levels, and muscle total cre-
atine content.
Serum and Muscle Creatine
Studies have shown the acute ingestion of 5 g and 20 g of
creatine monohydrate to increase serum levels of creatine
[5]. The recommended loading and maintenance dosages
for creatine ethyl ester are 10 g and 5 g, respectively. As a
result, in the present study participants ingested twice the
recommended dose of creatine ethyl ester, yet the CRT
group resulted in significantly higher levels of serum crea-
tine than the CEE group (Figure 1). Total muscle creatine
for the CRT group was significantly greater than the PLA
group, but not the CEE group. However, in light of ingest-
ing twice the recommended dose of creatine ethyl ester,
total muscle creatine concentration for the CEE group was
not significantly different from either the PLA or CRT
groups (Figure 2). There was a significant increase in total
muscle creatine levels for the CRT at day 6 and 27; how-
ever, for CEE an increase was observed to occur at day 27.
This is in agreement with most other studies showing sig-
nificant increases in muscle creatine [3,20-22].
Serum Creatinine
For serum creatinine, the CEE group underwent signifi-
cant increases compared to the PLA and CRT groups at
days 6 and 48 (Figure 3). In the CEE group, creatinine lev-
els increased 3-fold after the loading phase, and contin-
ued to be elevated above normal values throughout the
study. This observation can likely be based on the premise
that creatine ethyl ester has been shown to be degraded to
creatinine in stomach acid (Tallon). Creatinine levels for
the CRT group did elevate, but stayed within the normal
range of 0.8–1.3 mg/dL, while the PLA group stayed near
baseline levels. Serum creatinine is of importance because
Changes in muscle total creatine with data expressed as mean (± SD) Figure 2
Changes in muscle total creatine with data expressed as mean (± SD). † indicates a significant difference among 
groups where the PLA group was significantly less than the CRT (p = 0.026) and CEE (p = 0.041) groups. * indicates significant 
differences over the course of the four testing sessions where CRT increased at day 6 (p = 0.041) and 27 (p= 0.036), and CEE 
only increased at day 27 (p = 0.043).Journal of the International Society of Sports Nutrition 2009, 6:6 http://www.jissn.com/content/6/1/6
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creatinine is the by-product of creatine degradation. Crea-
tine is non-enzymatically converted into creatinine at
approximately 1.7% daily for a typical 70 kg individual
[23]. Creatine is also degraded by the gut into creatinine
at an estimated rate of 0.1 g of a 5 g dose per hour. This
indicates that the GI tract is not a major source of creati-
nine production; therefore, skeletal muscle is the primary
site of creatinine production. [13,24]. With increases in
muscle saturation of creatine, creatinine levels will
increase due to reduction in the skeletal muscle uptake
[1]. In the CRT group, skeletal muscle total creatine con-
tent underwent a significant increase at day 6 and 27,
whereas the CEE group only increased at day 27. In light
of the results for serum creatine and total muscle creatine,
based on the premise that serum creatinine levels for CEE
were significantly increased at days 6 and 48 (Figures 2
&3) our results seem to indicate that creatine esterification
does not provide a superior alternative to creatine mono-
hydrate for muscle creatine uptake.
Supplementation was based on fat-free mass for all groups
but was comparable to a 20 g loading phase and a 5 g
maintenance phase typically seen with creatine supple-
mentation. When creatine is esterified with an alcohol
group, the structure yields approximately 17.4 g of creat-
ine for a 20 g dose and 4.37 g for a 5 g dosage [14]. The
recommended loading and maintenance dosages for crea-
tine ethyl ester are 10 g and 5 g, respectively. The supple-
ment loading phase in the present study consisted of two
10 g dosages based on the premise that for a 10 g dose,
maximal absorption usually occurs within two hours [13].
Blood draws were not taken specifically after supplemen-
tation, yet serum creatinine levels were approximately tri-
pled at day 6 (2.68 ± SD 1.53 mg/dL) compared to
baseline (0.95 ± SD 0.18 mg/dL) for the CEE group.
Muscle Mass and Body Composition
Non-resistance trained participants were selected to per-
form a 47-day (4 days/week) training program and were
expected to have changes in muscle mass and body com-
position, independent of supplementation. Compared to
Changes in serum creatinine with data expressed as mean (± SD) Figure 3
Changes in serum creatinine with data expressed as mean (± SD). † indicates that CEE was greater than PLA (p = 
0.001) and CRT (p = 0.001). * indicates significant elevations in CEE at days 6 (p = 0.007), 27 (p = 0.005), and 48 (p = 0.005).Journal of the International Society of Sports Nutrition 2009, 6:6 http://www.jissn.com/content/6/1/6
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day 0, all groups showed significant increases in body
weight at each of the three testing sessions (Table 3).
While all groups increased in total body mass, there was
no significant difference between the three groups. Vari-
ous studies have shown an average of 1–2 kg of total body
mass increases with 20 g/day of creatine supplementation
for 5–7 days [4,21,23,25]. Total body mass increases after
the 5-day loading phase were 0.03 ± 0.60 kg, 1.39 ± 0.46
kg, and 0.80 ± 0.51 kg for PLA, CRT, and CEE, respectively.
Kreider [8] indicated that short duration (5–7 days) of cre-
atine supplementation at 20–25 g/day typically leads to
increases of up to 1.6 kg in total body mass. The total body
mass increase observed with the CRT group was within
typical ranges previously seen [26,27], even though there
were no significant differences between the groups. For fat
mass, fat-free mass, and thigh mass there were no signifi-
cant differences between any of the three groups. How-
ever, collectively fat-free mass was shown to increase at
days 6, 27, and 48 compared to day 0. Fat-free mass was
also significantly increased at days 27 and 48 compared to
day 6 (Table 3). Fat-free mass increases after the 5-day
loading phase were 0.55 ± 0.46 kg, 1.41 ± 0.29 kg, and
0.68 ± 0.42 kg for PLA, CRT, and CEE, respectively. Previ-
ous studies have shown that longer duration (12 weeks)
of creatine supplementation with resistance exercise [28]
and shorter duration (5 days loading and 4 days of main-
tenance) creatine supplementation to increase fat-free
mass [29]. As anticipated with an untrained population,
increases in body mass and fat-free mass were expected
due to a training effect. In line with fat-free mass increases,
thigh muscle mass increases were also observed through-
out the duration of the study. Thigh mass increases after
the 5-day loading phase were 0.10 ± 0.04 kg, 0.24 ± 0.53
kg, and 0.48 ± 0.02 kg for PLA, CRT, and CEE, respectively.
In contrast to total body mass and fat-free mass, the CRT
group showed the largest increase in thigh muscle mass
(Table 3). Fat mass was shown to significantly decrease at
days 6, 27, and 48. Both PLA and CRT groups had reduc-
Table 3: Body Composition Variables
Variables Day 0 Day 6 Day 27 Day 48
Body Weight (kg) * (p = 0.015) * (p = 0.006) * (p = 0.027)
PLA 77.91 (18.36) 77.94 (17.76) 78.52 (18.64) 78.80 (18.50)
CRT 89.42 (22.08) 90.76 (22.60) 90.55 (22.54) 90.09 (22.86)
CEE 73.69 (14.94) 74.49 (14.48) 74.91 (15.19) 75.32 (15.21)
Fat-Free Mass (kg) * (p = 0.001) * (p = 0.001) * (p = 0.001)
PLA 54.55 (10.05) 55.10 (9.60) 56.05 (10.19) 56.25 (10.22)
CRT 63.27 (10.79) 64.68 (11.18) 65.54 (11.68) 65.12 (11.39)
CEE 59.06 (8.46) 59.74 (8.16) 60.01 (8.52) 60.11 (8.11)
Fat Mass (kg) * (p = 0.002) * (p = 0.001) * (p = 0.003)
PLA 14.34 (8.92) 13.80 (8.65) 13.66 (8.89) 13.68 (8.94)
CRT 21.55 (12.63) 21.09 (12.40) 20.20 (12.06) 20.08 (12.15)
CEE † (p = 0.043) 10.44 (7.28) 10.41 (7.49) 10.50 (7.59) 10.88 (7.88)
Thigh Mass (kg) * (p = 0.017) * (p = 0.016)
PLA 8.07 (1.77) 8.17 (1.73) 8.31 (1.73) 8.36 (1.71)
CRT 8.93 (1.78) 9.17 (1.79) 9.28 (1.84) 9.34 (1.93)
CEE 7.58 (.81) 8.06 (1.35) 8.22 (1.31) 8.21 (1.36)
Data are expressed as mean (± SD). * indicates a significant difference at the respective testing session. † indicates a significant difference between 
groups (p < 0.05).Journal of the International Society of Sports Nutrition 2009, 6:6 http://www.jissn.com/content/6/1/6
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tions in fat mass throughout the study, whereas CEE
underwent a slight increase (Table 3). Specifically, fat
mass was shown to decrease 0.64 ± 0.08 kg and 1.47 ±
0.35 kg, respectively, whereas the CEE group increased
0.44 ± 0.68 kg. Although not statistically significant, it
should be noted that the CRT group had a higher baseline
fat mass than the PLA and CEE groups. Even though total
body mass and fat-free mass were not statistically differ-
ent, the CRT group may have had a greater potential for
reductions in fat mass than the CEE group. As such, the
reduction of fat mass observed with the PLA, CRT, and
CEE groups was mostly likely due to the resistance train-
ing rather than supplementation.
Table 4: Body Water Variables
Variables Day 0 Day 6 Day 27 Day 48
Total Body Water (L) * (p = 0.022) * (p = 0.001)
PLA 42.36 (8.68) 43.32 (7.86) 44.23 (8.56) 44.79 (7.49)
CRT 46.34 (6.38) 46.74 (6.72) 47.62 (7.16) 48.98 (7.28)
CEE 41.51 (5.77) 42.32 (5.36) 43.11 (6.20) 43.46 (6.10)
Intracellular Body Water (L) * (p = 0.023) * (p = 0.001)
PLA 24.90 (5.94) 26.15 (4.77) 26.57 (5.04) 27.42 (4.30)
CRT 27.91 (3.97) 28.19 (3.96) 29.05 (4.53) 30.43 (4.62)
CEE 25.03 (3.98) 24.90 (3.78) 25.87 (4.11) 26.04 (4.03)
Extracellular Body Water (L) * (p = 0.042)
PLA 16.94 (3.80) 17.12 (3.30) 17.66 (3.79) 17.36 (3.29)
CRT 18.44 (2.52) 15.56 (2.87) 18.58 (2.71) 18.55 (2.73)
CEE 16.47 (2.06) 17.42 (1.71) 17.25 (2.20) 17.42 (2.24)
Data are expressed as mean (± SD). * indicates a significant difference at the respective testing session (p < 0.05).
Table 5: Relative 1-RM Strength Variables
Variable Day 0 Day 6 Day 27 Day 48
Relative Bench Press Strength * (p = 0.001) * (p = 0.001)
PLA 1.04 (.26) 1.10 (.22) 1.12 (.20) 1.15 (.20)
CRT 1.06 (.20) 1.06 (.22) 1.14 (.21) 1.21 (.22)
CEE 1.05 (.28) 1.07 (.30) 1.10 (.29) 1.12 (.29)
Relative Leg Press Strength * (p = 0.021) * (p = 0.001) * (p = 0.001)
PLA 3.55 (.93) 3.70 (.99) 3.90 (.99) 3.83 (.96)
CRT 3.37 (.53) 3.40 (.54) 3.72 (.66) 3.85 (.81)
CEE 3.46 (.71) 3.63 (.72) 3.79 (.67) 3.87 (.72)
Values are represented as means (± SD). * indicates a significant difference at the respective testing session (p < 0.05).Journal of the International Society of Sports Nutrition 2009, 6:6 http://www.jissn.com/content/6/1/6
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Body Water
Total, intracellular, and extracellular body water are of
particular interest for the CEE group. Claims by the man-
ufactures of creatine ethyl ester have stated a difference in
the retention of body water compared to other forms of
creatine, specifically creatine monohydrate. Through the
use of the esterfication process, creatine is alleged to
become more permeable to the sarcolemma and bypass
the creatine transporter, thereby allowing more creatine to
enter the cell and minimize the amount of extracellular
water retained during supplementation. A potential bene-
fit of creatine supplementation is through the action of an
anabolic signal for skeletal muscle hypertrophy, with
increases in total and intracellular water [5,13]. Roughly
two-thirds of the increases in total body water seen during
supplementation are intracellular, with no fluid shift
occurring [30,31]. Mean increases in total body water
(Table 4) from day 0 to day 48 were 2.43 ± 1.19 L, 2.64 ±
0.31 L, and 1.95 ± 0.90 L for PLA, CRT, and CEE groups,
respectively. For all groups, total body water was shown to
significantly increase at days 27 and 48 compared to day
0. Mean increases in intracellular body water (Table 4)
from day 0 to 48 were 2.52 ± 1.63 L, 2.52 ± 0.006 L and
1.01 ± 0.65 L for PLA, CRT, and CEE groups, respectively,
and intracellular body water was significantly increased at
days 27 and 48. For extracellular water, mean increases
from day 0 to 48 were 0.42 ± 0.37 L 0.11 ± 0.18 L and 0.50
± 0.21 L for PLA, CRT, and CEE groups, respectively,
whereas extracellular body water was only significantly
increased at day 27 (Table 4).
Collectively, changes in total, intracellular, and extracellu-
lar body water were not significantly different between the
supplement and placebo groups. However, the mean
increases for total and intracellular body water from day 0
to 48 were greatest for the CRT group. Extracellular water
increases from baseline were actually largest for the CEE
groups. Therefore, claims by the manufactures of creatine
ethyl ester stating that extracellular water retention is min-
imized were shown to be unfounded by the present study.
Previous research has shown creatine supplementation to
increase total body water, yet no fluid shift occurs [30]. In
resistance-trained participants, increases in total body
water with creatine supplementation, but not a placebo,
during resistance training have been observed [32]. In
contrast, in the present study the participants were not
resistance-trained, with increases in body water observed
in the PLA group. Because resistance training is associated
with increases in body water [33], the changes observed in
the present study were mostly likely due to the resistance
training program itself rather than the supplementation.
Muscle Strength and Power
Various studies have shown improvements in muscle
strength and power through the use of creatine supple-
mentation [1,20,28]. Bench press strength was shown to
increase at days 27 and 48 compared to day 0 (Figure 1),
whereas leg press strength showed an increase at day 6, 27,
and 48 compared to day 0 (Table 5). However, in both
instances there were no differences between the three
groups. Mean and peak power showed a significant
improvement over the course of the study (Table 6). How-
ever, the muscle power measures had no significant differ-
ences between the three groups. Other studies have shown
no benefits for increases in muscle power with supple-
mentation [34].
An increase in muscle performance typically correlates
with an increase in creatine muscle uptake [20]. Even
though there was no significant increase in total muscle
Table 6: Wingate Muscle Power Variables
Variable Day 0 Day 6 Day 27 Day 48
Mean Power (W/kg) * (p = 0.046) * (p = 0.019)
PLA 623 (136) 633 (154) 636 (166) 657 (177)
CRT 679 (128) 695 (127) 724 (128) 713 (128)
CEE 615 (93) 648 (97) 642 (111) 648 (97)
Peak Power (W/kg) * (p = 0.001)
PLA 1171 (238) 1197 (313) 1174 (229) 1305 (256)
CRT 1258 (243) 1208 (215) 1322 (214) 1326 (211)
CEE 1107 (202) 1210 (181) 1196 (193) 1251 (174)
Values are represented as means (± SD). * indicates a significant difference at the respective testing session (p < 0.05).Journal of the International Society of Sports Nutrition 2009, 6:6 http://www.jissn.com/content/6/1/6
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creatine content with the supplement groups over the
course of the study. The PLA group, which did not con-
sume creatine, showed similar improvements in muscle
strength and performance. Therefore, our data indicates
the improvements that were observed were most likely
from the strength training program, not due to the creat-
ine supplements.
Conclusion
Creatine ethyl ester did not show any additional benefit to
increase muscle strength or performance than creatine
monohydrate or maltodextose placebo. Additionally,
total body mass, fat mass, fat-free mass, and thigh muscle
mass were not significantly enhanced with creatine ethyl
ester supplementation compared to placebo or creatine
monohydrate groups. Increases in body water were simi-
lar to the placebo and creatine monohydrate groups. The
vast majority of the improvement observed in the present
study can most likely be attributed to the training protocol
itself, rather than the supplementation. Since creatine
ethyl ester supplementation showed a large increase in
serum creatinine levels throughout the study with no sig-
nificant increase in serum and total muscle creatine con-
tent, it can be concluded that a large portion of the
creatine ethyl ester was being degraded within the GI tract
after ingestion. Furthermore, it appears that the skeletal
muscle uptake of creatine ethyl ester uptake was not sig-
nificant enough to increase skeletal muscle creatine levels
without significant degradation to creatinine occurring.
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